These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24799298)

  • 1. Neuropeptide Y, social function and long-term outcome in schizophrenia.
    Stålberg G; Ekselius L; Lindström LH; Larhammar D; Bodén R
    Schizophr Res; 2014 Jul; 156(2-3):223-7. PubMed ID: 24799298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.
    Nikisch G; Baumann P; Liu T; Mathé AA
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1051-61. PubMed ID: 22008251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures.
    Peters J; Van Kammen DP; Gelernter J; Yao J; Shaw D
    Schizophr Res; 1990; 3(5-6):287-94. PubMed ID: 2178001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment.
    Olsson A; Regnéll G; Träskman-Bendz L; Ekman R; Westrin A
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):479-85. PubMed ID: 15589387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later.
    Ventura J; Subotnik KL; Gitlin MJ; Gretchen-Doorly D; Ered A; Villa KF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2015 Feb; 161(2-3):407-13. PubMed ID: 25499044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites.
    Harvey PD; Howanitz E; Parrella M; White L; Davidson M; Mohs RC; Hoblyn J; Davis KL
    Am J Psychiatry; 1998 Aug; 155(8):1080-6. PubMed ID: 9699697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia.
    Sasayama D; Hattori K; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    Schizophr Res; 2012 Aug; 139(1-3):201-6. PubMed ID: 22742979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.
    Gjerris A; Widerlöv E; Werdelin L; Ekman R
    J Psychiatry Neurosci; 1992 Mar; 17(1):23-7. PubMed ID: 1349825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms at index admission as predictor for 1-5 year outcome in schizophrenia.
    Wieselgren IM; Lindström E; Lindström LH
    Acta Psychiatr Scand; 1996 Nov; 94(5):311-9. PubMed ID: 9124077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic variables at intake and long-term level of function in schizophrenia.
    Siegel SJ; Irani F; Brensinger CM; Kohler CG; Bilker WB; Ragland JD; Kanes SJ; Gur RC; Gur RE
    Am J Psychiatry; 2006 Mar; 163(3):433-41. PubMed ID: 16513864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study.
    Helldin L; Kane JM; Hjärthag F; Norlander T
    Schizophr Res; 2009 Nov; 115(1):67-73. PubMed ID: 19666215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively.
    Widerlöv E; Lindström LH; Wahlestedt C; Ekman R
    J Psychiatr Res; 1988; 22(1):69-79. PubMed ID: 3397912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of symptom remission in schizophrenia during inpatient treatment.
    Jäger M; Riedel M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Bottlender R; Strauss A; Möller HJ
    World J Biol Psychiatry; 2009; 10(4 Pt 2):426-34. PubMed ID: 17853260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological markers for outcome in schizophrenia: a review of a longitudinal follow-up study in Uppsala schizophrenia research project.
    Lindström LH
    Neuropsychopharmacology; 1996 Mar; 14(3 Suppl):23S-26S. PubMed ID: 8866740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
    Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
    J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social skills training for schizophrenic individuals at risk for relapse.
    Liberman RP; Mueser KT; Wallace CJ
    Am J Psychiatry; 1986 Apr; 143(4):523-6. PubMed ID: 2869704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recovery and remission in schizophrenia. Results from a naturalistic 2-year follow-up inpatient study].
    Wolter A; Preuss U; Krischke N; Wong JW; Langosch JM; Zimmermann J
    Fortschr Neurol Psychiatr; 2010 Aug; 78(8):468-74. PubMed ID: 20694939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts.
    Sandberg JV; Jakobsson J; Pålsson E; Landén M; Mathé AA
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1907-15. PubMed ID: 25453484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.